Roundhill GLP-1 & Weight Loss ETF
OZEM
#2806
ETF rank
C$69.46 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$41.85
Share price
-0.50%
Change (1 day)
24.13%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of March 27, 2026Number of holdings: 28

Full holdings list

Weight %NameTickerShares Held
16.03%
Eli Lilly & CoLLY9003
13.28%
Novo Nordisk A/SNVO183834
7.57%
Pfizer IncPFE138419
5.68%
Viking Therapeutics IncVKTX83569
4.88%
Innovent Biologics Inc1801 HK242500
4.67%
Ascletis Pharma Inc1672 HK1133000
4.06%
Hanmi Pharm Co Ltd128940 KS5593
4.04%
Amgen IncAMGN5762
4.03%
Roche Holding AGROP SW5146
3.59%
Zealand Pharma A/SZEAL DC40685
3.57%
AstraZeneca PLCAZN9819
3.45%
Chugai Pharmaceutical Co Ltd4519 JP32800
3.33%
Regeneron Pharmaceuticals IncREGN2218
3.16%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK662500
2.69%
CSPC Pharmaceutical Group Ltd1093 HK1298000
2.54%
Gubra A/SGUBRA DC22723
2.37%
United Laboratories International Holdings Ltd/The3933 HK954000
2.33%
Structure Therapeutics IncGPCR25378
1.92%
MBX Biosciences IncMBX34264
1.91%
Gilead Sciences IncGILD7043
1.40%
Shionogi & Co Ltd4507 JP32700
1.38%
Rhythm Pharmaceuticals IncRYTM8463
0.94%
Biohaven LtdBHVN53094
0.76%
First American Government Obligations Fund 12/01/2031FGXXX382033.33
0.41%
Corbus Pharmaceuticals Holdings IncCRBP22131
0.40%
WaVe Life Sciences LtdWVE32778
0.15%
Cash & OtherCash&Other77218.16
-0.54%
SWISS FRANCCHF-215321.29